Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of 552-02 in Cystic Fibrosis
NCT00274313Phase 2Completed
- Sponsor
- Parion Sciences
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 552-02 in cystic fibrosis (CF), sponsored by Parion Sciences. Started Jan 2006; status: completed.
02
Drugs
552-02
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00274313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274313.